The distinct phenotypic characteristics of the two B cell subsets means that combined analysis of CD19 and/or CD20 with light scatter characteristics provides useful clinical phenotype to monitor their presence in peripheral blood of MM patients. The gene discussed is CD19; the disease is Miyoshi myopathy.